Erratum: The management of atrial fibrillation: Summary of updated NICE guidance (British Medical Journal (2014) 348, (g3655) DOI: 10.1136/bmj.g3655);The management of atrial fibrillation: Summary of updated NICE guidance

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Jones, Clare ^a   Pollit, Vicki ^a   Fitzmaurice, David ^b   Cowan, Campbell ^c  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DABIGATRAN ETEXILATE; DIGOXIN; DILTIAZEM; NONSTEROID ANTIINFLAMMATORY AGENT; RIVAROXABAN; WARFARIN;

ABLATION THERAPY; AGE; ALCOHOL CONSUMPTION; ASTHMA; BLEEDING; BRADYCARDIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; COGNITION; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET; ELECTROCARDIOGRAPHY; HAS BLED SCORE; HEALTH CARE ORGANIZATION; HEART ARRHYTHMIA; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART RHYTHM; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE; PALPATION; PATIENT COMPLIANCE; PATIENT REFERRAL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PHARMACOLOGICAL PARAMETERS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SINUS RHYTHM; SYSTEMATIC REVIEW (TOPIC); THORAX SURGERY; THROMBOEMBOLISM; TIME IN THERAPEUTIC RANGE; TRANSIENT ISCHEMIC ATTACK; TREATMENT CONTRAINDICATION;

ACADEMIES AND INSTITUTES; ADRENERGIC BETA-ANTAGONISTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; DISEASE MANAGEMENT; ELECTROENCEPHALOGRAPHY; HUMANS; LIFE STYLE; PRACTICE GUIDELINES AS TOPIC; STROKE;

EID: 84902583672     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g4440     Document Type: Erratum

References (18)

1. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837-47.
2. National Institute for Health and Care Excellence. Support for commissioning: anticoagulation therapy. 2013. http://publicationsniceorg.uk/ support-for-commissioning-anticoagulation-therapy-cmg49/1-key-issues-in- commissioning-anticoagulation-therapy
3. Cowan C, Healicon R, Robson I, Long WR, Barrett J, Fay M, et al. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart 2013;99:1166-72.
4. Holt TA, Hunter TD, Gunnarsson C, Khan N, Cload P, Lip GYH. Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey. Br J Gen Pract 2012;62:e710-7.
5. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010;123:638-45.
6. National Institute for Health and Care Excellence. Atrial fibrillation: the management of atrial fibrillation. (Clinical guideline 180.) 2014. http://guidance.nice.org.uk/CG180.
7. National Institute for Health and Care Excellence. Patient experience in adult NHS services: improving the experience of care for people using adult NHS services. (Clinical guideline 138.) 2012. http://guidance.nice.org.uk/CG138.
8. National Institute for Health and Care Excellence. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. (Clinical guideline 144.) 2012. http://guidance.nice.org. uk/CG144.
9. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72.
10. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-100.
11. National Institute for Health and Care Excellence. Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation. NICE technology appraisal guidance 256. 2012. www.nice.org.uk/nicemedia/live/ 13746/59295/59295.pdf.
12. National Institute for Health and Care Excellence. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. NICE technology appraisal guidance 249. 2012. http://guidance.nice.org.uk/TA249.
13. National Institute for Health and Care Excellence. Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation. NICE technology appraisal guidance 275. 2013. www.nice.org.uk/ nicemedia/live/14086/62874/62874.pdf.
14. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-9. (Pubitemid 23069000)
15. Mant J, Hobbs FDR, Fletcher K, Roalfe A, Fitzmaurice D, Lip GYH, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
16. National Institue for Health and Care Excellence. Developing NICE clinical guidelines. 2013. www.nice.org.uk/aboutnice/howwework/ developingniceclinicalguidelines/developing-nice-clinical-guidelines.jsp.
17. GRADE Working Group. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group website. www.gradeworkinggroup. org/.
18. Lord J, Willis S, Eatock J, Tappenden P, Trapero-Bertran M, Miners A, et al. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project. Health Technol Assess 2013;17:1-192.